Encyclopedia

  • Characterization, stability, and pharmacokinetics of Sibutramine (cas 106650-56-0)/β-cyclodextrin inclusion complex
  • Add time:08/08/2019         Source:sciencedirect.com

    β-Cyclodextrin (β-CD) is widely used to increase the stability, solubility, and bioavailability of poorly soluble drugs because of the appropriate size of its cavity. Sibutramine is a neurotransmitter reuptake inhibitor that has been investigated as an oral anorexiant. Here we report the complexation of sibutramine base with β-CD and the stability, dissolution, and pharmacokinetic properties of the sibutramine/CD complex. The formation of sibutramine/β-CD inclusion complexes is confirmed using differential scanning calorimetry, X-ray diffractometry, and 1H nuclear magnetic resonance. The thermal and photochemical stability of sibutramine is significantly improved by the complexation with β-CD, and the pharmacokinetic parameters (e.g., the plasma concentration, area under the curve, and maximum concentration of two active metabolites) for humans are comparable with those of the commercialized standard product (Reductil®). Our study suggests that sibutramine/β-CD complexation can be of great use to increase the stability and biological efficacy of sibutramine base.

    We also recommend Trading Suppliers and Manufacturers of Sibutramine (cas 106650-56-0). Pls Click Website Link as below: cas 106650-56-0 suppliers


    Prev:Influence of acute treatment with Sibutramine (cas 106650-56-0) on the sympathetic neurotransmission of the young rat vas deferens
    Next: Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of Sibutramine (cas 106650-56-0) therapy: A crucial role for the CYP2B6*6 allele)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View